Zyprexa Related Published Studies
Well-designed clinical trials related to Zyprexa (Olanzapine)
A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for
emesis induced by highly emetogenic chemotherapy. [2015]
Sleep architecture and cognitive changes in olanzapine-treated patients with
depression: a double blind randomized placebo controlled trial. [2014]
Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a
randomized, double-blind, placebo controlled study. [2014]
Long-term effects of asenapine or olanzapine in patients with persistent negative
symptoms of schizophrenia: a pooled analysis. [2013]
A randomized controlled trial of olanzapine improving memory deficits in Han
Chinese patients with first-episode schizophrenia. [2013]
Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of
bipolar depression. [2013]
Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely
agitated patient: a multicenter, randomized, double-blind, placebo-controlled
clinical trial. [2013]
Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical
study from India. [2013]
Association of common variations in the norepinephrine transporter gene with
response to olanzapine-fluoxetine combination versus continued-fluoxetine
treatment in patients with treatment-resistant depression: a candidate gene
analysis. [2012]
Factors associated with non-completion in a double-blind randomized controlled
trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic
depression. [2012]
Efficacy and safety of olanzapine in the treatment of Japanese patients with
bipolar I disorder in a current manic or mixed episode: a randomized,
double-blind, placebo- and haloperidol-controlled study. [2012]
Risperidone and olanzapine versus another first generation antipsychotic in
patients with schizophrenia inadequately responsive to first generation
antipsychotics. [2012]
A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. [2011.10]
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia. [2011.09.23]
Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. [2011.09]
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). [2011.09]
Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. [2011.09]
The GiSAS study: rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia. [2011.09]
Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes. [2011.08.15]
Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder. [2011.08]
A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. [2011.06]
Genetic variation in CYP3A43 explains racial difference in olanzapine clearance. [2011.06]
Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison. [2011.06]
Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study. [2011.05.17]
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. [2011.05]
Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. [2011.04]
Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. [2011.03]
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia. [2011.02.15]
Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study. [2011.02]
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). [2011.02]
Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. [2011.02]
An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. [2011.01.15]
Dose correspondence between olanzapine long-acting injection and oral olanzapine: recommendations for switching. [2011.01]
A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. [2011]
Bioequivalence evaluation of two oral formulations of quetiapine fumarate in healthy volunteers. [2011]
A placebo-controlled pilot study of adjunctive olanzapine for adolescents with
anorexia nervosa. [2011]
Change in level of productivity in the treatment of schizophrenia with olanzapine
or other antipsychotics. [2011]
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective
disorder: results of an 8-week double-blind randomized controlled trial. [2011]
The effect of Olanzapine and Sertraline on personality disorder in patients with methadone maintenance therapy. [2010.12]
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials. [2010.12]
Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. [2010.12]
Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders. [2010.11.20]
Symptoms predicting remission after divalproex augmentation with olanzapine in partially nonresponsive patients experiencing mixed bipolar I episode: a post-hoc analysis of a randomized controlled study. [2010.11.02]
Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. [2010.10]
Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. [2010.09]
Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice. [2010.09]
Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. [2010.08.24]
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. [2010.07]
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study. [2010.07]
Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes. [2010.06.09]
Risperidone versus olanzapine for the treatment of delirium. [2010.06]
Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder. [2010.06]
Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. [2010.06]
Olanzapine: in adolescents with schizophrenia or bipolar I disorder. [2010.05.01]
Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial. [2010.05]
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. [2010.05]
Olanzapine vs. lithium in management of acute mania. [2010.05]
A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. [2010.04.20]
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. [2010.04.20]
Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study. [2010.04.20]
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. [2010.03.24]
Modeling the effectiveness of paliperidone ER and olanzapine in schizophrenia: meta-analysis of 3 randomized, controlled clinical trials. [2010.03]
Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial. [2010.03]
Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial. [2010.02]
Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. [2010.02]
Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. [2010.01.30]
Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets. [2010.01]
Effects on cognitive functioning after olanzapine-ziprasidone crossover in
recent-onset schizophrenia. [2010]
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in
recent onset schizophrenia. [2010]
Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset
seizures. [2010]
A randomized, double-blind, placebo-controlled trial of olanzapine in the
treatment of trichotillomania. [2010]
Olanzapine: in adolescents with schizophrenia or bipolar I disorder. [2010]
Olanzapine/fluoxetine combination in patients with treatment-resistant
depression: rapid onset of therapeutic response and its predictive value for
subsequent overall response in a pooled analysis of 5 studies. [2010]
Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia
or schizoaffective disorder. [2010]
Olanzapine versus haloperidol in the management of borderline personality
disorder: a randomized double-blind trial. [2010]
Modeling the effectiveness of paliperidone ER and olanzapine in schizophrenia:
meta-analysis of 3 randomized, controlled clinical trials. [2010]
Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients
Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized,
Double-blind, Placebo-Controlled Trial. [2010]
Genetic associations of prolactin increase in olanzapine/fluoxetine
combination-treated patients. [2010]
Olanzapine vs. lithium in management of acute mania. [2010]
Asenapine versus olanzapine in acute mania: a double-blind extension study. [2009.12]
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study. [2009.11]
Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.11]
Mifepristone treatment of olanzapine-induced weight gain in healthy men. [2009.10]
Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. [2009.10]
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. [2009.09.23]
Olanzapine-Divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.09.22]
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). [2009.08]
Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. [2009.08]
A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study. [2009.08]
Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction? [2009.07]
Olanzapine compared to quetiapine in adolescents with a first psychotic episode. [2009.07]
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. [2009.07]
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. [2009.07]
Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial. [2009.06.19]
Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men. [2009.06]
Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. [2009.05]
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. [2009.05]
Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. [2009.05]
An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects. [2009.04.01]
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. [2009.04]
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. [2009.04]
|
